|
2023-03-10 |
2023-03-10 |
B
Purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
51,599,200
+889.5%
27.00
1,393,178,400
USD
|
51,599,200
+889.5%
|
27.00
|
1,393,178,400
USD
|
|
|
2023-01-20 |
2023-01-18 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
1,109
-0.4%
26.89
29,821
USD
|
1,109
-0.4%
|
26.89
|
29,821
USD
|
|
|
2023-01-20 |
2023-01-18 |
S
Sale
|
Merendino Lauren
Chief Commercial Officer
Officer
|
2,008
-1.2%
26.89
53,995
USD
|
2,008
-1.2%
|
26.89
|
53,995
USD
|
|
|
2023-01-20 |
2023-01-18 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
1,272
-0.4%
26.89
34,204
USD
|
1,272
-0.4%
|
26.89
|
34,204
USD
|
|
|
2023-01-20 |
2023-01-18 |
S
Sale
|
Marek David C
Principal Executive Officer
Executive Director
|
8,037
-1.9%
26.89
216,115
USD
|
8,037
-1.9%
|
26.89
|
216,115
USD
|
|
|
2023-01-05 |
2023-01-04 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
2,251
-0.9%
26.90
60,552
USD
|
2,251
-0.9%
|
26.90
|
60,552
USD
|
|
|
2023-01-05 |
2023-01-04 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
2,779
-0.8%
26.90
74,755
USD
|
2,779
-0.8%
|
26.90
|
74,755
USD
|
|
|
2022-12-20 |
2022-12-16 |
S
Sale
|
Mehra Uneek
Principal Financial Officer
Officer
|
2,241
-1.1%
26.75
59,947
USD
|
2,241
-1.1%
|
26.75
|
59,947
USD
|
|
|
2022-10-20 |
2022-10-18 |
S
Sale
|
Marek David C
Principal Executive Officer
Executive Director
|
11,156
-2.6%
25.20
281,131
USD
|
11,156
-2.6%
|
25.20
|
281,131
USD
|
|
|
2022-10-20 |
2022-10-18 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
1,604
-0.6%
25.20
40,421
USD
|
1,604
-0.6%
|
25.20
|
40,421
USD
|
|
|
2022-10-20 |
2022-10-18 |
S
Sale
|
Merendino Lauren
Chief Commercial Officer
Officer
|
1,703
-1.0%
25.20
42,916
USD
|
1,703
-1.0%
|
25.20
|
42,916
USD
|
|
|
2022-10-20 |
2022-10-18 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
1,933
-0.5%
25.20
48,712
USD
|
1,933
-0.5%
|
25.20
|
48,712
USD
|
|
|
2022-10-06 |
2022-10-04 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
3,679
-1.0%
24.40
89,768
USD
|
3,679
-1.0%
|
24.40
|
89,768
USD
|
|
|
2022-10-06 |
2022-10-04 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
2,738
-1.1%
24.40
66,807
USD
|
2,738
-1.1%
|
24.40
|
66,807
USD
|
|
|
2022-09-20 |
2022-09-16 |
S
Sale
|
Mehra Uneek
Principal Financial Officer
Officer
|
9,243
-4.3%
18.86
174,323
USD
|
9,243
-4.3%
|
18.86
|
174,323
USD
|
|
|
2022-08-16 |
2022-08-15 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
31,214
-7.9%
18.23
569,031
USD
|
31,214
-7.9%
|
18.23
|
569,031
USD
|
|
|
2022-07-20 |
2022-07-18 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
1,606
-0.6%
12.87
20,669
USD
|
1,606
-0.6%
|
12.87
|
20,669
USD
|
|
|
2022-07-20 |
2022-07-18 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
1,935
-0.7%
12.87
24,903
USD
|
1,935
-0.7%
|
12.87
|
24,903
USD
|
|
|
2022-07-20 |
2022-07-18 |
S
Sale
|
Merendino Lauren
Chief Commercial Officer
Officer
|
1,704
-1.0%
12.87
21,930
USD
|
1,704
-1.0%
|
12.87
|
21,930
USD
|
|
|
2022-07-20 |
2022-07-18 |
S
Sale
|
Marek David C
Principal Executive Officer
Executive Director
|
11,164
-2.5%
12.87
143,681
USD
|
11,164
-2.5%
|
12.87
|
143,681
USD
|
|
|
2022-07-08 |
2022-07-06 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
2,755
-1.1%
13.40
36,917
USD
|
2,755
-1.1%
|
13.40
|
36,917
USD
|
|
|
2022-07-08 |
2022-07-06 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
3,702
-1.3%
13.40
49,607
USD
|
3,702
-1.3%
|
13.40
|
49,607
USD
|
|
|
2022-06-01 |
2022-05-27 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
1,382
-0.5%
10.07
13,917
USD
|
1,382
-0.5%
|
10.07
|
13,917
USD
|
|
|
2022-04-21 |
2022-04-19 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
4,632
-1.7%
10.45
48,404
USD
|
4,632
-1.7%
|
10.45
|
48,404
USD
|
|
|
2022-04-21 |
2022-04-19 |
S
Sale
|
Merendino Lauren
Chief Commercial Officer
Officer
|
7,049
-3.9%
10.45
73,662
USD
|
7,049
-3.9%
|
10.45
|
73,662
USD
|
|
|
2022-04-21 |
2022-04-19 |
S
Sale
|
Marek David C
Principal Executive Officer
Executive Director
|
24,594
-5.2%
10.45
257,007
USD
|
24,594
-5.2%
|
10.45
|
257,007
USD
|
|
|
2022-04-21 |
2022-04-19 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
8,002
-2.8%
10.45
83,621
USD
|
8,002
-2.8%
|
10.45
|
83,621
USD
|
|
|
2022-04-07 |
2022-04-05 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
1,922
-1.2%
13.78
26,485
USD
|
1,922
-1.2%
|
13.78
|
26,485
USD
|
|
|
2022-04-07 |
2022-04-05 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
2,436
-1.4%
13.78
33,568
USD
|
2,436
-1.4%
|
13.78
|
33,568
USD
|
|
|
2022-03-03 |
2022-03-01 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
1,362
-0.8%
13.35
18,183
USD
|
1,362
-0.8%
|
13.35
|
18,183
USD
|
|
|
2022-01-21 |
2022-01-19 |
S
Sale
|
Marek David C
Principal Executive Officer
Executive Director
|
19,882
-5.6%
14.68
291,868
USD
|
19,882
-5.6%
|
14.68
|
291,868
USD
|
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
2,271
-1.4%
16.27
36,949
USD
|
2,271
-1.4%
|
16.27
|
36,949
USD
|
|
|
2022-01-06 |
2022-01-04 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
4,475
-2.5%
16.27
72,808
USD
|
4,475
-2.5%
|
16.27
|
72,808
USD
|
|
|
2021-12-01 |
2021-11-29 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
1,978
-1.2%
19.30
38,175
USD
|
1,978
-1.2%
|
19.30
|
38,175
USD
|
|
|
2021-11-05 |
2021-11-04 |
PS
Planned sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
3,100
-1.8%
24.02
74,462
USD
|
3,100
-1.8%
|
24.02
|
74,462
USD
|
|
|
2021-11-05 |
2021-11-03 |
PS
Planned sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
700
-0.4%
24.00
16,800
USD
|
700
-0.4%
|
24.00
|
16,800
USD
|
|
|
2021-10-07 |
2021-10-05 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
2,738
-1.6%
21.62
59,196
USD
|
2,738
-1.6%
|
21.62
|
59,196
USD
|
|
|
2021-10-07 |
2021-10-05 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
6,671
-3.6%
21.62
144,227
USD
|
6,671
-3.6%
|
21.62
|
144,227
USD
|
|
|
2021-09-29 |
2021-09-27 |
PS
Planned sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
7,000
-3.9%
24.32
170,240
USD
|
7,000
-3.9%
|
24.32
|
170,240
USD
|
|
|
2021-09-28 |
2021-09-27 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
2,232
+0.0%
24.86
55,486
USD
|
2,232
+0.0%
|
24.86
|
55,486
USD
|
|
|
2021-09-28 |
2021-09-27 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
45,768
+0.1%
24.19
1,106,904
USD
|
45,768
+0.1%
|
24.19
|
1,106,904
USD
|
|
|
2021-09-28 |
2021-09-24 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
36,000
+0.1%
23.40
842,548
USD
|
36,000
+0.1%
|
23.40
|
842,548
USD
|
|
|
2021-09-14 |
2021-09-13 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
30,028
+0.1%
23.91
717,990
USD
|
30,028
+0.1%
|
23.91
|
717,990
USD
|
|
|
2021-09-14 |
2021-09-13 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
53,150
+0.1%
23.09
1,227,058
USD
|
53,150
+0.1%
|
23.09
|
1,227,058
USD
|
|
|
2021-09-14 |
2021-09-10 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
30,000
+0.1%
25.11
753,390
USD
|
30,000
+0.1%
|
25.11
|
753,390
USD
|
|
|
2021-09-13 |
2021-09-09 |
PS
Planned sale
|
Curran Terrie
Non-Executive Director
|
4,850
-100.0%
25.58
124,063
USD
|
4,850
-100.0%
|
25.58
|
124,063
USD
|
|
|
2021-09-01 |
2021-08-31 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
39,000
+0.1%
24.28
946,885
USD
|
39,000
+0.1%
|
24.28
|
946,885
USD
|
|
|
2021-09-01 |
2021-08-30 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
70,000
+0.1%
23.92
1,674,099
USD
|
70,000
+0.1%
|
23.92
|
1,674,099
USD
|
|
|
2021-08-30 |
2021-08-27 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
37,038
+0.1%
23.17
858,252
USD
|
37,038
+0.1%
|
23.17
|
858,252
USD
|
|
|
2021-08-30 |
2021-08-26 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
40,000
+0.1%
22.67
906,912
USD
|
40,000
+0.1%
|
22.67
|
906,912
USD
|
|
|
2021-08-20 |
2021-08-19 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
46,792
+0.1%
21.51
1,006,421
USD
|
46,792
+0.1%
|
21.51
|
1,006,421
USD
|
|
|
2021-08-20 |
2021-08-18 |
PP
Planned purchase
|
Sumitomo Chemical Co., Ltd.
Large shareholder
|
17,116
+0.0%
21.45
367,092
USD
|
17,116
+0.0%
|
21.45
|
367,092
USD
|
|
|
2021-06-02 |
2021-05-28 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
1,783
-1.0%
24.00
42,792
USD
|
1,783
-1.0%
|
24.00
|
42,792
USD
|
|
|
2021-06-02 |
2021-05-28 |
PS
Planned sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
1,300
-0.7%
24.00
31,200
USD
|
1,300
-0.7%
|
24.00
|
31,200
USD
|
|
|
2021-05-28 |
2021-05-26 |
PS
Planned sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
12,700
-6.7%
24.23
307,721
USD
|
12,700
-6.7%
|
24.23
|
307,721
USD
|
|
|
2021-04-08 |
2021-04-06 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
8,114
-6.0%
18.63
151,164
USD
|
8,114
-6.0%
|
18.63
|
151,164
USD
|
|
|
2021-04-08 |
2021-04-06 |
S
Sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
10,862
-7.4%
18.62
202,250
USD
|
10,862
-7.4%
|
18.62
|
202,250
USD
|
|
|
2021-03-23 |
2021-03-19 |
PS
Planned sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
7,000
-4.9%
24.17
169,190
USD
|
7,000
-4.9%
|
24.17
|
169,190
USD
|
|
|
2021-03-17 |
2021-03-15 |
PS
Planned sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
30,000
-17.1%
25.07
752,013
USD
|
30,000
-17.1%
|
25.07
|
752,013
USD
|
|
|
2021-03-03 |
2021-03-01 |
S
Sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
1,513
-1.1%
22.55
34,118
USD
|
1,513
-1.1%
|
22.55
|
34,118
USD
|
|
|
2021-02-18 |
2021-02-16 |
PS
Planned sale
|
KARBE FRANK
Principal Fin'l & Accounting
Officer
|
750
-0.5%
21.40
16,050
USD
|
750
-0.5%
|
21.40
|
16,050
USD
|
|
|
2021-02-01 |
2021-01-28 |
PS
Planned sale
|
KARBE FRANK
Principal Fin'l & Accounting
Officer
|
300
-0.2%
24.00
7,200
USD
|
300
-0.2%
|
24.00
|
7,200
USD
|
|
|
2021-01-20 |
2021-01-15 |
PS
Planned sale
|
KARBE FRANK
Principal Fin'l & Accounting
Officer
|
750
-0.5%
21.50
16,125
USD
|
750
-0.5%
|
21.50
|
16,125
USD
|
|
|
2020-12-30 |
2020-12-28 |
PS
Planned sale
|
KARBE FRANK
Principal Fin'l & Accounting
Officer
|
11,800
-6.7%
30.00
354,000
USD
|
11,800
-6.7%
|
30.00
|
354,000
USD
|
|
|
2020-12-22 |
2020-12-18 |
PS
Planned sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
2,000
-1.4%
26.00
52,000
USD
|
2,000
-1.4%
|
26.00
|
52,000
USD
|
|
|
2020-12-22 |
2020-12-18 |
PS
Planned sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
300
-0.2%
26.24
7,871
USD
|
300
-0.2%
|
26.24
|
7,871
USD
|
|
|
2020-12-22 |
2020-12-18 |
PS
Planned sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
9,700
-6.2%
25.38
246,183
USD
|
9,700
-6.2%
|
25.38
|
246,183
USD
|
|
|
2020-12-17 |
2020-12-15 |
PS
Planned sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
3,467
-2.5%
24.18
83,837
USD
|
3,467
-2.5%
|
24.18
|
83,837
USD
|
|
|
2020-12-17 |
2020-12-15 |
PS
Planned sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
3,533
-2.5%
23.66
83,589
USD
|
3,533
-2.5%
|
23.66
|
83,589
USD
|
|
|
2020-12-17 |
2020-12-15 |
PS
Planned sale
|
KARBE FRANK
Principal Fin'l & Accounting
Officer
|
670
-0.4%
24.45
16,383
USD
|
670
-0.4%
|
24.45
|
16,383
USD
|
|
|
2020-12-17 |
2020-12-15 |
PS
Planned sale
|
KARBE FRANK
Principal Fin'l & Accounting
Officer
|
380
-0.2%
23.63
8,980
USD
|
380
-0.2%
|
23.63
|
8,980
USD
|
|
|
2020-12-14 |
2020-12-10 |
PS
Planned sale
|
Arjona Ferreira Juan Camilo
Chief Medical Officer
Officer
|
10,000
-6.8%
26.04
260,362
USD
|
10,000
-6.8%
|
26.04
|
260,362
USD
|
|
|
2020-12-11 |
2020-12-10 |
PS
Planned sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
19,400
-11.7%
25.20
488,783
USD
|
19,400
-11.7%
|
25.20
|
488,783
USD
|
|
|
2020-12-11 |
2020-12-09 |
PS
Planned sale
|
Lang Matthew
General Counsel & Corp. Secy.
Officer
|
600
-0.4%
25.08
15,049
USD
|
600
-0.4%
|
25.08
|
15,049
USD
|
|
|
2020-12-02 |
2020-11-30 |
PS
Planned sale
|
KARBE FRANK
Principal Fin'l & Accounting
Officer
|
1,500
-0.9%
24.00
36,000
USD
|
1,500
-0.9%
|
24.00
|
36,000
USD
|
|
